Proactive Investors - Run By Investors For Investors

Canopy Growth acquires London skincare company This Works for $54 million

CEO Bruce Linton says CBD has the potential to ‘disrupt the cosmetic and sleep solution industries’
A generic representation of an acquisition
Canopy is armed with a more than $4 billion balance sheet courtesy of an investment from Corona beer maker Constellation Brands

Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) announced Wednesday it is buying London-based skincare and wellness company This Works for 43 million pounds ($54 million) in cash. 

Founded in London, England in 2004, This Works offers a range of natural skincare and sleep solution products including deep sleep pillow spray, morning expert hyaluronic serum and skin-deep dry leg oil. 

This Works will be an integral part of Canopy Growth’s entry into the natural wellness industry and further bolsters the world's biggest cannabis company’s international presence.

READ: Canopy Growth acquires German cannabinoid pharmaceutical company C3

This Works chief executive Anna Persaud will remain at the helm of the business once the deal has closed.

"As a leading wellness brand and a pioneer in sleep beauty products, we are passionate about the opportunity CBD offers beauty consumers,” said Dr Persaud. “Canopy Growth will provide the expertise, research, scientific rigor and quality assurance that will allow This Works to drive the agenda in wellness beauty's ever-evolving market."

In January this year, Canopy Growth announced Spectrum Biomedical UK, a joint venture between Canopy and Oxford-based research company Beckley Canopy Therapeutics to address the need for high-quality cannabis-based medicinal products in the UK.

"We believe CBD has the potential to disrupt the cosmetic and sleep solution industries and have been working for years to build and establish the right entry point into this opportunity," said Canopy Growth CEO Bruce Linton. "As soon as we met with Dr Persaud and her team, we knew they were the right partner to embark with on this journey."

Canopy is armed with a more than $4 billion balance sheet to snap up targets thanks to investment from Corona beer maker Constellation Brands Inc (NYSE:STZ).

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full WEED profile View Profile

Canopy Growth Corporation Timeline

Related Articles

medicinal cannabis concept
January 30 2019
Zelda has released its December quarterly report confirming multiple trials are on track.
Sydney Harbour Bridge
January 22 2019
A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.
A cannabis plant shown next to an oil-based product
April 23 2019
THC is executing a medicinal cannabis strategy in Australia, New Zealand and Canada and is looking to Asian markets.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use